Topas Therapeutics
Company Details
Status: Private
Employees: 11-50
Location:
Hamburg, Germany
Type:
sample
Technology:
sample
sample
sample
sample
About: Topas Therapeutics is a clinical-stage biotechnology company transforming the field of immune tolerance with a novel antigen-specific and targeted nanoparticle technology. Our antigen-coupled nanoparticle platform harnesses the tolerogenic power of the liver to treat autoimmune diseases. Our proprietary Topas Particles Conjugates target liver sinusoidal endothelial cells, a specific type of antigen-presenting cells highly effective at inducing T cell tolerance.
With a technology adjustable to a broad spectrum of disease-relevant antigens, we have established a growing and advanced clinical pipeline to induce systemic tolerance.
To learn more visit https://topas-therapeutics.com/
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Topas Therapeutics | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.